AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr |
What is the latest Revenue of AJANTA PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹4,209 Cr |
| Mar2024 | ₹3,743 Cr |
| Mar2023 | ₹3,341 Cr |
| Mar2022 | ₹2,890 Cr |
| Mar2021 | ₹2,588 Cr |
How is Revenue of AJANTA PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,209 Cr | 12.45 | |
| Mar2024 | ₹3,743 Cr | 12.02 | |
| Mar2023 | ₹3,341 Cr | 15.62 | |
| Mar2022 | ₹2,890 Cr | 11.66 | |
| Mar2021 | ₹2,588 Cr | - | |
Compare Revenue of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹33,483.2 Cr | 5.5% | 9.3% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 5.5% |
9.3% |
-6.5% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses